Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of four protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection, Human Vaccines & Immunotherapeutics, September 2017, Taylor & Francis,
DOI: 10.1080/21645515.2017.1368598.
You can read the full text:
Contributors
The following have contributed to this page